Search
Communities with poor access to mental health services are eight times more likely to be youth suicide hotspots, according to new The Kids Research Institute Australia research.
Prominent consultant psychiatrist and Western Australia’s 2021 Australian of the Year, Professor Helen Milroy AM, has been recognised as a Member of the Order of Australia (General Division).
Two researchers focused on improving outcomes for children with chronic lung disease and averting suicide contagion and suicide clusters in young people have won prestigious Investigator Grants from the National Health and Medical Research Council.
Congratulations Dr Nicole Hill, who has been honoured at this year’s prestigious 40under40 Awards for her outstanding contributions to suicide prevention research in Australia.
The Kids Research Institute Australia congratulates Professor Helen Milroy on being named Western Australia’s 2021 Australian of the Year.
Experiencing stigma is associated with a range of negative outcomes for people with mental health disorders. However, little is understood about the contemporary stigma experiences of young people with anxiety and depression. This study aimed to describe these experiences using semi-structured qualitative interviews.
Pete Azzopardi PhD, FRACP, MEpi, MBBS, GDipBiostats, BMedSci Head, Adolescent Health and Wellbeing Head, Adolescent Health and Wellbeing Professor
To estimate the prevalence, distribution, and co-occurrence of mental ill-health and substance use among gender and sexuality diverse young people relative to their cisgender and heterosexual peers in Australia using population-level, nationally representative data.
The prevalence of psychosis has been shown to be disproportionately high amongst sexual and gender minority individuals. However, there is currently little consideration of the unique needs of this population in mental health treatment, with LGBTQA+ individuals facing barriers in accessing timely and non-stigmatising support for psychotic experiences.
Prescriptions for atypical antipsychotics in children and adolescents are increasing globally. However, a precise understanding of the clinical variables and evidence that prescribers consider before using these agents is lacking.